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ABSTRACT
The incidence of primary malignant melanoma 
(MM) and skin carcinomas, including basal cell car-
cinoma (BCC) and squamous cell carcinoma (SCC), 
is progressively raising. As long as their diagnosis and 
therapeutic managements are initiated early, their prog-
nosis remains favorable. This underlines the importance 
of early recognition of skin cancers. Furthermore, it has 
been demonstrated that skin cancer screening programs 
are efﬁ cacious in increasing the population awareness 
of the early signs of skin cancer and of the dangers of 
UV – exposure. 
A skin cancer screening campaign was organised by 
dermatologists of the German-speaking Community of 
Belgium in cooperation with the department of Family, 
Health, and Social Affairs of the Regional Ministry of 
the German-speaking Community of Belgium. In order 
to increase the screening selectivity, two risk populations 
were targeted; patients presenting 30 or more moles, 
and patients over 50 years of age presenting recent skin 
changes of the head and neck area. A media campaign 
using radio, television and daily press was started to 
increase the population awareness of the dangers of UV 
exposure and of the early signs of skin cancer. During 2 
screening days, three-hour sessions were organised in 2 
health centers located in Eupen and St Vith. A total of 
148 patients were examined. 
A total of 124/148 patients met the selection criteria 
predeﬁ ned during the media announcement. The simulta-
neous presence of 4 dermatologists during the screening 
sessions allowed a second opinion for warning lesions. 
Four BBCs as well as 23 patients pesenting dysplastic 
nevi were clinically diagnosed. During the 2 months fol-
lowing the screening campaign 5 MMs were identiﬁ ed 
by the same dermatologists in their routine practice.
In conclusion, this skin cancer screening campaign 
led to the diagnosis of 4 carcinomas. The campaign fur-
thermore increased the patient awareness, permitting the 
diagnosis of 5 MMs during the 2 following months. This 
ﬁ gure represents about 30% of all MMs diagnosed yearly 
in this region of Belgium.
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INTRODUCTION
The prevalence of skin carcinomas, including basal 
cell carcinoma (BCC) and squamous cell carcinoma 
(SCC), and of malignant melanoma (MM) is on the 
rise over the past decades (1-11). Even if BCCs present 
almost no risk of dissemination, serious tumor- and 
treatment-related morbidity may be associated with 
large inﬁ ltrating lesions (12-14). Although the risk of 
metastasis is low for small size SCC, it may lead to 
serious morbidity (6,12,15-18). The danger of MM is 
linked to the development of metastases often associated 
with a very poor prognosis. The risk of metastasis and 
the prognosis of MM are strongly related to the primary 
tumor thickness and to the sentinel lymph node invasion 
(19,20).
Various types of skin cancer screening campaigns (1) 
have been organised at a large scale in the USA (21), 
Australia (22-24), and in Europe (25). These campaigns 
have proven to be useful by several aspects. They en-
couraged self-examination (4,26), provided educatio-
nal messages about sun protection, and helped in early 
detection of MM and skin carcinomas during and after 
the campaigns (27-30). Patient education and self-exa-
mination increases the impact of ofﬁ ce-based screening 
and mass screening programs (27,31,32). Even if the 
number of new cases of skin cancer disclosed during 
these campaigns may appear limited, a main beneﬁ t is 
the increase of new cases diagnosed in the months fol-
lowing the campaigns (25).
Visual examination by dermatologists has been pro-
ven effective for skin cancer screening purposes (1). 
Dermoscopy represents a valuable tool to complement 
visual examination (33,34). In the recent years, retros-
pective data show 10-15 new cases of MM in the about 
70.000 inhabitants of the German-speaking Community 
of Belgium (data gathered over 8 years from the labo-
ratory for pathology, Sankt Nikolaus Hospital Eupen, 
and the laboratory for dermatopathology of the Liège 
University).
Due to its particular linguistic status, the former Bel-
gian Melanoma Monday and the current Euromelanoma 
campaigns were never successfully organised in the Ger-
man-speaking Community of Belgium. The department 
of Family, Health, and Social Affairs of the Ministry of 
the German-speaking community and the dermatologists 
practicing in this region organised a targeted skin cancer 
screening campaign in 2003. It was previously reported 
that screening focused on MM increases the detection 
of lesions suggestive of MM and dysplastic nevi, but 
decreased the proportions of disclosed BCC, SCC and 
actinic keratoses (35). As our goal was to screen all skin 
cancers, the media campaign provided information about 
each major type of skin cancer. Two weeks before the 
screening days, a media campaign involving the radio, 
television and daily press was launched. It dealt with skin 
cancers, sun protection, how to decrease skin cancer risk 
and how to recognize the early signs of skin cancers. It 
is acknowledged that screening never proved to help in 
reducing the MM mortality rates (28,30,36-39). Scree-
ning should rather target risk groups (40). Therefore, 
two risk populations were solicited, namely patients 
presenting 30 moles or more, and patients over the age 
of 50 years presenting recent skin changes in the head 
and neck area.. Skin changes were deﬁ ned as skin lesions 
that had appeared recently, or lesions that had recently 
begun to scale, to bleed and/or to crust. Patients who met 
the selection criteria were invited to present themselves 
at the screening centers. A centralised appointment ofﬁ ce 
was operative using a single phone call number where 
patients were orally screened and controlled on the 
selection criteria. The patients were then dispatched to 
one of the two screening centres located in Eupen and 
St Vith. During two screening days, the patients were 
examined randomly by one of the 4 dermatologists who 
were simultaneously devoted to skin cancer screening 
for 3 hours. Furthermore, patients were provided with 
an information sheet about skin cancers, sun avoidance, 
and dangers of UV-exposure.
MATERIALS AND METHODS
The following data were recorded during the scree-
ning campaign: age, gender, occupation (indoor or out-
door), phototype (I to V), sunburns during infancy (<12 
years) (frequent or rare), current and past use of tanning 
UV-delivering devices (1, 5, 10, or more than 10 sessions 
per year), patient meeting the selection criteria (yes or 
no), number of diagnostic opinions regarding the present 
skin tumors, and the clinical and dermoscopy diagnosis 
of the screened lesions. A total body skin examination 
was performed on every patient. Nevi exhibiting mor-
phological changes such as asymmetry, irregular borde-
res and color variation were given the clinical diagnosis 
of dysplastic or atypical nevus.
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RESULTS
A total number of 148 patients (M:62, F:86) was 
sceened during the 2 days. The age distribution is shown 
in Table 1. The screening program appeared to be more 
attractive with increasing age.
The vast majority of the screened individuals belonged 
to light skin and photosensitive groups (phototypes 1: 
10,8%, 2: 53,4%, 3: 34,5%, 4: 1,4% respectively). 
A total of 24/148 (17,6%) of the screened patients 
had used self-tanning UV-delivering devices either at 
home or in a sun parlour. Of these individuals 8,3% 
had 1 session per year, 33,3% had 5 sessions per year, 
33,3% had 10 sessions per year, and 25% had more than 
10 sessions per year
The percentage of patients recalling sunburns during 
infancy reached 81,8 % (45,2% rarely, 36,5% frequent-
ly). Data were similar in the 2 screening centers.
The total number of patients meeting the predeﬁ ned 
selection criteria was 124/148 (83,7%) (Table 1). The 
adherence to the selection criterion 1 (patients presenting 
over 30 nevi) was higher compared to criterion 2 (pa-
tients over the age of 50 presenting recent skin changes 
in the head and neck area) (56,7% versus 27%). No diffe-
rences were yielded between the 2 screening centers. Of 
the 84 patients meeting criterion 1, the age distribution 
is presented in table 1. The phototype distribution was 
the following; type 1: 12%, 2: 67%, 3: 33%, 4: 0% res-
pectively). Sunburn was recalled in 89,1% (75 patients, 
60% (40 patients) frequently, 40% rarely (35 patients)). 
Sunbed use was noted in 15 patients (17,8%) (6,6% had 
1 session per year, 20% had 5 sessions per year, 26,6% 
had 10 sessions per year, and 46,6% had more than 10 
sessions per year). 
Of the 40 patients responding to criterion 2, the age 
distribution is given in table 1. The phototype distribu-
tion was the following; type 1: 2,5%, 2: 30%, 3: 65%, 
4: 2,5% respectively). Sunburn was recalled in 85% (34 
patients, 58,8% (20 patients) frequently, 41,2% rarely (14 
patients)). Sunbed use was noted in 9 patients (22,5%) 
(11,1% had 1 session per year, 11,1% had 5 sessions per 
year, 33,3% had 10 sessions per year, and 44,4% had 
more than 10 sessions per year).
The clinical and dermoscopic diagnoses (if applica-
ble) are summarized in table 2 for the total cohort as well 
as the two predeﬁ ned groups. Excision of the maligant 
lesions was adviced. Strict surveillance of atypical nevi 
and actinic keratosis was also adviced. 
During the 2 months following the campaign, 5 histo-
logically proven MM were detected by the participating 
dermatologists.
DISCUSSION
The global incidence of MM and skin carcinomas has 
steadily and rapidly increased over the past 2 decades 
(1-11). Skin carcinomas are seldom lethal, but, if advan-
ced, can cause severe disﬁ gurement and morbidity. Early 
detection and treatment of MM should reduce mortality 
rates, while early detection and treatment of skin carci-
nomas might prevent morbidity and to a lesser degree 
prevent mortality. These data underline the importance 
of early detection and therapy. 
Skin cancer screening campaigns have proven to be 
successful in achieving public education on skin cancers 
and their risk factors (26-32). Indeed, increased public 
awareness regarding skin cancer probably represents the 
main impact of skin cancer screening programs (41).
The present targeted skin cancer screening campaign 
has achieved different goals. During the screening days, 
4 cases of skin carcinomas were clinically diagnosed. In 
addition, during the following 2 months, 5 histologically 
proven cases of MM were detected by the participating 
dermatologists. This ﬁ gure represents about 30% of 
the total number of MM detected yearly in this Bel-
gian region. An increased number of consultations for 
pigmentary lesions was also experienced. Furthermore, 
the media campaign increased the population awareness 
of skin cancers, promoted effective sun protection and 
make known the dangers of excessive UV-exposures. 
As preselection of at risk patients increases the ef-
ﬁ cacy of screening programs (27,31,32), two patient 
Table 1: Age distribution in the total cohort and in the criterion 1 and criterion 2 groups.
Age 0-10 11-20 21-30 31-40 41-50 51-60 61-70 71-80 81-90 Total
Total 3 9 11 38 16 30 29 11 1 148
Crit 1 3 8 9 20 13 14 11 6 0 84
Crit 2 0 0 0 0 0 16 18 5 1 40
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populations were targeted via the media. A total number 
of 83,7% of the screened patients met the predetermined 
criteria. The criterion « 30 or more moles » achieved 
signiﬁ cantly higher scores compared to the criterion 
« recent skin changes ». This could be partially related 
to the Melanoma Monday and Euromelanoma campaigns 
focussing particularly on MM (25). This ﬁ gure may also 
be partially due to the centralised appointment ofﬁ ce 
enabling a preselection. The most frequently encountered 
patient misjudgement were multiple seborrheic keratoses 
and lentiginosis. When the criterion 1 group is conside-
red, it is noted that sunbed use is more frequent and more 
often compared to the entire screened patient group. The 
diagnosis of melanocytic nevi as well as dysplastic nevi 
was effectively particularly high in group 1 compared to 
group 2. Furthermore, all the cases of skin cancer and 
the majority of cases of actinic keratosis were effectively 
diagnosed in criterion group 2. Although the total cohort 
is too limited to achieve signiﬁ cative statistics, the results 
demonstrate the interest of preselection.
The simultaneous presence of 4 dermatologists was 
useful for opinion exchanges about puzzling lesions. In 
particular, diagnosing dysplastic nevus was often subject 
to second opinion.
In conclusion, the skin cancer screening campaign 
performed in the German-speaking Community of Bel-
gium led to the diagnosis of 4 cases of skin carcinomas 
during the screening days. It probably invited the 5 
patients with MM to consult during the 2 following 
months. In addition, patient awareness was increased 
on skin cancer issues, prevention methods as well as on 
the long-term dangers of UV-exposure. This probably 
represents the main positive impact of the campaign. 
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